<h2>Afya 股票：近期表现的背景</h2>
<p>Afya（NasdaqGS:AFYA）在许多投资者的雷达上，因为其股价经历了波动，过去一天上涨约 2.3%，但在过去一周和一个月内有所下跌。</p>
<p>请查看我们对 Afya 的最新分析。</p>
<p>放眼长远，Afya 一年总股东回报下降 10.1%，五年总股东回报下降 37.9%，这表明尽管最近股价上涨至 $13.97，但股价动能正在减弱。</p>
<p>如果 Afya 最近的波动让你重新评估你的观察名单，这可能是一个好时机去扫描其他吸引投资者注意的医疗股票。</p>
<p>在 Afya 的交易价格为 $13.97，价值评分为 6，并且显示出收入和净收入增长的迹象时，你不得不问：这个定价仍然保守吗，还是市场已经在考虑未来的收益？</p>
<h2>9.2 倍市盈率：是否合理？</h2>
<p>Afya 最近收盘价为 $13.97，市盈率为 9.2 倍，相较于同行和更广泛的消费服务行业，该股票显得便宜。</p>
<p>市盈率将当前股价与每股收益进行比较，因此较低的市盈率可能表明市场为每单位当前收益分配了较低的价格。</p>
<p>Afya 在多个方面被认为是良好的价值，包括其交易价格低于 Simply Wall St 估计的公允价值 53.1%，并且获得了 6 的价值评分。这些因素共同表明，市场对 Afya 的定价低于其收益状况和每年约 14% 的预测增长所通常暗示的水平。</p>
<p>当你查看同行时，这一差距也很明显，Afya 的 9.2 倍市盈率远低于同行平均的 40.5 倍和美国消费服务行业平均的 16.9 倍。它也低于市场可能在情绪与基本面一致时逐渐接近的估计公允市盈率 16.9 倍。</p>
<p>探索 Afya 的 SWS 公允比率</p>
<p><strong>结果：9.2 倍市盈率（被低估）</strong></p>
<p>然而，长期的总股东回报下降以及对巴西医疗教育市场的依赖可能限制了市场对这一低市盈率的情绪恢复速度。</p>
<p>了解这一 Afya 叙述的主要风险。</p>
<h2>另一种观点：DCF 指向更大的差距</h2>
<p>Afya 在 9.2 倍市盈率上已经显得便宜，但我们的 DCF 模型进一步表明，股票交易价格为 $13.97，而估计的未来现金流价值为 $29.80。这是一个很大的差距。市场是否过于谨慎，还是看到了模型无法捕捉的风险？</p>
<p>了解 SWS DCF 模型如何得出其公允价值。</p>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/7b116eaf-c65d-4800-9595-403a47a74e12/chart/dcf?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" width="1706" height="760" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/7b116eaf-c65d-4800-9595-403a47a74e12/chart/dcf"/></p>
<p>截至 2026 年 1 月的 AFYA 折现现金流</p>
<p>Simply Wall St 每天对全球每只股票进行折现现金流（DCF）分析（例如查看 Afya）。我们展示了完整的计算过程。你可以在你的观察名单或投资组合中跟踪结果，并在变化时收到提醒，或者使用我们的股票筛选器发现 883 只基于现金流被低估的股票。如果你保存了筛选器，我们甚至会在新公司匹配时提醒你——这样你就不会错过潜在的机会。</p>
<h2>构建你自己的 Afya 叙述</h2>
<p>如果这个框架并不完全符合你对 Afya 的看法，你可以随时自己查看数据并塑造一个反映你自己观点的叙述，按你的方式来。</p>
<p>一个好的起点是我们的分析，强调投资者对 Afya 的 5 个关键回报的乐观预期。</p>
<h2>寻找更多投资想法？</h2>
<p>如果 Afya 让你思考更深，不要止步于此。更广泛的观察名单可以帮助你发现适合你风格和风险承受能力的机会。</p>
<ul>
<li>通过扫描这些 883 只基于现金流被低估的股票，寻找潜在的错误定价，这些股票的市场定价可能基于其现金流而显得保守。</li>
<li>通过审查这 24 只正在塑造下一波技术的 AI 便士股票，发现自动化和数据的新兴趋势。</li>
<li>通过考虑这 19 只与区块链、数字资产和新支付网络相关的加密货币和区块链股票，增加多样化潜力。</li>
</ul>
<p><em>这篇文章由 Simply Wall St 撰写，内容具有一般性。<strong>我们提供基于历史数据和分析师预测的评论，采用无偏见的方法，我们的文章并不旨在提供财务建议。</strong> 它不构成购买或出售任何股票的推荐，也未考虑你的目标或财务状况。我们的目标是为你提供以基本数据驱动的长期分析。请注意，我们的分析可能未考虑最新的价格敏感公司公告或定性材料。Simply Wall St 在提到的任何股票中没有持仓。</em></p>

AFYA

<p>Afya（纳斯达克代码：AFYA）目前的交易价格为 13.97 美元，市盈率为 9.2 倍，表明其相较于同行和消费服务行业可能被低估。尽管最近上涨了 2.3%，但 Afya 在过去一年中总股东回报下降了 10.1%。折现现金流（DCF）分析显示其公允价值为 29.80 美元，突显出显著的差距。建议投资者在评估 Afya 的潜在风险和回报时考虑其他医疗保健股票</p>

<h2>Afya stock: context for recent performance</h2>
<div class="lb-trans"><h2>Afya 股票：近期表现的背景</h2>
</div><p>Afya (NasdaqGS:AFYA) has been on many investors’ radars after a mixed stretch in the share price, with a roughly 2.3% gain over the past day but declines over the past week and month.</p>
<div class="lb-trans"><p>Afya（NasdaqGS:AFYA）在许多投资者的雷达上，因为其股价经历了波动，过去一天上涨约 2.3%，但在过去一周和一个月内有所下跌。</p>
</div><p>See our latest analysis for Afya.</p>
<div class="lb-trans"><p>请查看我们对 Afya 的最新分析。</p>
</div><p>Zooming out, Afya’s 1 year total shareholder return decline of 10.1% and 5 year total shareholder return decline of 37.9% suggest recent share price momentum has been fading despite the latest move to $13.97.</p>
<div class="lb-trans"><p>放眼长远，Afya 一年总股东回报下降 10.1%，五年总股东回报下降 37.9%，这表明尽管最近股价上涨至 $13.97，但股价动能正在减弱。</p>
</div><p>If Afya’s recent swings have you reassessing your watchlist, this could be a good moment to scan other healthcare stocks that are catching investors’ attention.</p>
<div class="lb-trans"><p>如果 Afya 最近的波动让你重新评估你的观察名单，这可能是一个好时机去扫描其他吸引投资者注意的医疗股票。</p>
</div><p>With Afya trading at $13.97, carrying a value score of 6 and signs of revenue and net income growth, you have to ask: is this pricing still conservative, or is the market already baking in future gains?</p>
<div class="lb-trans"><p>在 Afya 的交易价格为 $13.97，价值评分为 6，并且显示出收入和净收入增长的迹象时，你不得不问：这个定价仍然保守吗，还是市场已经在考虑未来的收益？</p>
</div><h2>Price-to-Earnings of 9.2x: Is it justified?</h2>
<div class="lb-trans"><h2>9.2 倍市盈率：是否合理？</h2>
</div><p>With Afya last closing at $13.97 and trading on a P/E of 9.2x, the stock screens as inexpensive compared to both peers and the broader Consumer Services industry.</p>
<div class="lb-trans"><p>Afya 最近收盘价为 $13.97，市盈率为 9.2 倍，相较于同行和更广泛的消费服务行业，该股票显得便宜。</p>
</div><p>The P/E ratio compares the current share price to earnings per share, so a lower P/E can suggest the market is assigning a lower price for each unit of current earnings.</p>
<div class="lb-trans"><p>市盈率将当前股价与每股收益进行比较，因此较低的市盈率可能表明市场为每单位当前收益分配了较低的价格。</p>
</div><p>Afya is flagged as good value on several fronts, including trading at 53.1% below the Simply Wall St estimate of its fair value and earning a value score of 6. Together these factors point to the market pricing Afya below what its earnings profile and forecast growth of around 14% per year might usually imply.</p>
<div class="lb-trans"><p>Afya 在多个方面被认为是良好的价值，包括其交易价格低于 Simply Wall St 估计的公允价值 53.1%，并且获得了 6 的价值评分。这些因素共同表明，市场对 Afya 的定价低于其收益状况和每年约 14% 的预测增长所通常暗示的水平。</p>
</div><p>The gap is also clear when you look at peers, with Afya's 9.2x P/E sitting well below the peer average of 40.5x and the US Consumer Services industry average of 16.9x. It is also below an estimated fair P/E of 16.9x that the market could, in time, move closer to if sentiment aligns with its fundamentals.</p>
<div class="lb-trans"><p>当你查看同行时，这一差距也很明显，Afya 的 9.2 倍市盈率远低于同行平均的 40.5 倍和美国消费服务行业平均的 16.9 倍。它也低于市场可能在情绪与基本面一致时逐渐接近的估计公允市盈率 16.9 倍。</p>
</div><p>Explore the SWS fair ratio for Afya</p>
<div class="lb-trans"><p>探索 Afya 的 SWS 公允比率</p>
</div><p><strong>Result: Price-to-Earnings of 9.2x (UNDERVALUED)</strong></p>
<div class="lb-trans"><p><strong>结果：9.2 倍市盈率（被低估）</strong></p>
</div><p>However, the longer term total shareholder return declines and reliance on Brazil’s medical education market could limit how quickly sentiment around that low P/E resets.</p>
<div class="lb-trans"><p>然而，长期的总股东回报下降以及对巴西医疗教育市场的依赖可能限制了市场对这一低市盈率的情绪恢复速度。</p>
</div><p>Find out about the key risks to this Afya narrative.</p>
<div class="lb-trans"><p>了解这一 Afya 叙述的主要风险。</p>
</div><h2>Another view: DCF points to a larger gap</h2>
<div class="lb-trans"><h2>另一种观点：DCF 指向更大的差距</h2>
</div><p>Afya already screens as inexpensive on a 9.2x P/E, yet our DCF model goes further, suggesting the shares are trading at $13.97 versus an estimated future cash flow value of $29.80. That is a wide gap. Is the market overdoing its caution, or seeing risks the model cannot?</p>
<div class="lb-trans"><p>Afya 在 9.2 倍市盈率上已经显得便宜，但我们的 DCF 模型进一步表明，股票交易价格为 $13.97，而估计的未来现金流价值为 $29.80。这是一个很大的差距。市场是否过于谨慎，还是看到了模型无法捕捉的风险？</p>
</div><p>Look into how the SWS DCF model arrives at its fair value.</p>
<div class="lb-trans"><p>了解 SWS DCF 模型如何得出其公允价值。</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/7b116eaf-c65d-4800-9595-403a47a74e12/chart/dcf" alt="" original-src="https://images.simplywall.st/company/7b116eaf-c65d-4800-9595-403a47a74e12/chart/dcf"/></p>
<p>AFYA Discounted Cash Flow as at Jan 2026</p>
<div class="lb-trans"><p>截至 2026 年 1 月的 AFYA 折现现金流</p>
</div><p>Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out Afya for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 883 undervalued stocks based on their cash flows. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.</p>
<div class="lb-trans"><p>Simply Wall St 每天对全球每只股票进行折现现金流（DCF）分析（例如查看 Afya）。我们展示了完整的计算过程。你可以在你的观察名单或投资组合中跟踪结果，并在变化时收到提醒，或者使用我们的股票筛选器发现 883 只基于现金流被低估的股票。如果你保存了筛选器，我们甚至会在新公司匹配时提醒你——这样你就不会错过潜在的机会。</p>
</div><h2>Build Your Own Afya Narrative</h2>
<div class="lb-trans"><h2>构建你自己的 Afya 叙述</h2>
</div><p>If this framework does not quite fit how you see Afya, you can always pull up the numbers yourself and shape a narrative that reflects your own view, Do it your way.</p>
<div class="lb-trans"><p>如果这个框架并不完全符合你对 Afya 的看法，你可以随时自己查看数据并塑造一个反映你自己观点的叙述，按你的方式来。</p>
</div><p>A good starting point is our analysis highlighting 5 key rewards investors are optimistic about regarding Afya.</p>
<div class="lb-trans"><p>一个好的起点是我们的分析，强调投资者对 Afya 的 5 个关键回报的乐观预期。</p>
</div><h2>Looking for more investment ideas?</h2>
<div class="lb-trans"><h2>寻找更多投资想法？</h2>
</div><p>If Afya has sharpened your thinking, do not stop here. A broader watchlist can help you spot opportunities that suit your style and risk tolerance.</p>
<div class="lb-trans"><p>如果 Afya 让你思考更深，不要止步于此。更广泛的观察名单可以帮助你发现适合你风格和风险承受能力的机会。</p>
</div><ul>
<li>Target potential mispricings by scanning these 883 undervalued stocks based on cash flows that the market may be pricing conservatively based on their cash flows.</li>
<li>Spot emerging trends in automation and data by reviewing these 24 AI penny stocks shaping the next wave of technology.</li>
<li>Add diversification potential by considering these 19 cryptocurrency and blockchain stocks linked to blockchain, digital assets, and new payment networks.</li>
</ul>
<div class="lb-trans"><ul>
<li>通过扫描这些 883 只基于现金流被低估的股票，寻找潜在的错误定价，这些股票的市场定价可能基于其现金流而显得保守。</li>
<li>通过审查这 24 只正在塑造下一波技术的 AI 便士股票，发现自动化和数据的新兴趋势。</li>
<li>通过考虑这 19 只与区块链、数字资产和新支付网络相关的加密货币和区块链股票，增加多样化潜力。</li>
</ul>
</div><p><em>This article by Simply Wall St is general in nature. <strong>We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.</strong> It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.</em></p>
<div class="lb-trans"><p><em>这篇文章由 Simply Wall St 撰写，内容具有一般性。<strong>我们提供基于历史数据和分析师预测的评论，采用无偏见的方法，我们的文章并不旨在提供财务建议。</strong> 它不构成购买或出售任何股票的推荐，也未考虑你的目标或财务状况。我们的目标是为你提供以基本数据驱动的长期分析。请注意，我们的分析可能未考虑最新的价格敏感公司公告或定性材料。Simply Wall St 在提到的任何股票中没有持仓。</em></p>
</div>

评估 Afya（纳斯达克股票代码：AFYA）的估值，当前其股票以 9.2 倍市盈率和折扣后的 DCF 价格进行交易